1-4 of 4
Rita B. Khouri
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase II Study of the Frontline Hyper-CVAD in Combination with Ponatinib for Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Koji Sasaki, MD, Elias J. Jabbour, MD, Farhad Ravandi, MD, Naval G. Daver, MD, Naveen Pemmaraju, MD, Deborah A Thomas, MD, Rita B. Khouri, Musa Yilmaz, MD, Tapan M. Kadia, MD, Nicholas J. Short, MD, Rebecca Garris, MS, Guillermo Garcia-Manero, MD, Courtney D DiNardo, MD, Marina Konopleva, MD PhD, Zeev Estrov, MD, Nitin Jain, MD, William G. Wierda, MD PhD, Twilla Victoria Jeanis, RN, Jorge E. Cortes, MD, Susan M. O'Brien, MD, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2016) 128 (22): 757.
https://doi.org/10.1182/blood.V128.22.757.757
Published: 2016
Journal Articles

Outcomes of Adult Patients with Relapsed/Refractory Burkitt or Burkitt-like Leukemia/Lymphoma

Nicholas J. Short, MD, Elias J. Jabbour, MD, Heidi Ko, MD, Farhad Ravandi, MD, Deborah A Thomas, MD, Guillermo Garcia-Manero, MD, Rita B. Khouri, Jorge E. Cortes, MD, William G. Wierda, MD PhD, Srdan Verstovsek, MD PhD, Zeev Estrov, MD, Alessandra Ferrajoli, MD, Philip A Thompson, MBBS, Sherry Pierce, BSN, BA, Hagop M. Kantarjian, MD
Journal: Blood
Blood (2016) 128 (22): 5150.
https://doi.org/10.1182/blood.V128.22.5150.5150
Published: 2016
Journal Articles

Updated Results of a Randomized Phase II Trial of Idarubicin and Cytarabine with Clofarabine or Fludarabine in Patients with Newly Diagnosed Acute Myeloid Leukemia

Nicholas J. Short, MD, Farhad Ravandi, MD, Xuelin Huang, PhD, Jorge E. Cortes, MD, Naveen Pemmaraju, MD, Naval Daver, MD, Rita B. Khouri, Gautam Borthakur, MD, Nitin Jain, MD, Marina Konopleva, MD PhD, Zeev Estrov, MD, Guillermo Garcia-Manero, MD, Tapan M. Kadia, MD, William G. Wierda, MD PhD, Courtney D DiNardo, MD, Susan M. O'Brien, MD, Syed Shah, Allison Pike, RN, Mark Brandt, BS, Hagop M. Kantarjian, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2016) 128 (22): 1067.
https://doi.org/10.1182/blood.V128.22.1067.1067
Published: 2016
Journal Articles

Frontline Ofatumumab in Combination with Hyper-CVAD for Adult Patients with CD-20 Positive Acute Lymphoblastic Leukemia (ALL): Interim Result of a Phase II Clinical Trial

Koji Sasaki, MD, Hagop M. Kantarjian, MD, Farhad Ravandi, MD, Naval Daver, MD, Tapan M. Kadia, MD, Rita B. Khouri, Yesid Alvarado, MD, Jan A. Burger, MD PhD, Deborah A Thomas, MD, Guillermo Garcia-Manero, MD, Courtney D DiNardo, MD, Naveen Pemmaraju, MD, Nicholas J. Short, MD, Heather Schroeder, RN, Rebecca Garris, MS, Prithviraj Bose, MD, Nitin Jain, MD, Kiran Naqvi, MD, William G. Wierda, MD PhD, Srdan Verstovsek, MD PhD, Jorge E. Cortes, MD, Marina Konopleva, MD PhD, Susan M. O'Brien, MD, Elias J. Jabbour, MD
Journal: Blood
Blood (2016) 128 (22): 2783.
https://doi.org/10.1182/blood.V128.22.2783.2783
Published: 2016